Cytokine responses to human immunodeficiency virus type I (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120

被引:11
|
作者
Gorse, GJ
Patel, GB
Mandava, MD
Arbuckle, JA
Doyle, TM
Belshe, RB
机构
[1] St Louis Univ, Sch Med, St Louis Dept Vet Affairs Med Ctr, St Louis, MO 63110 USA
[2] St Louis Univ, Sch Med, Div Infect Dis & Immunol, St Louis, MO 63110 USA
关键词
cell-mediated immunity; HIV-1; cytokines; vaccines;
D O I
10.1016/S0264-410X(00)00378-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccine-induced T-cell memory for human immunodeficiency virus type 1 (HIV-1) was assessed by measuring HIV-1 antigen-stimulated cytokine secretion in 72 HIV-1-uninfected subjects, of whom 52 received live recombinant canarypox virus vaccine expressing HIV-1 env, gag, and protease gene products (vCP205) with or without HIV-1(SF-2) recombinant gp120 (SF-2 rgp120) subunit vaccine, and 20 the control. The vCP205 vaccine induced secretion of the Th1 cytokine, interferon-gamma, by peripheral blood mononuclear cells (PBMC) after in vitro stimulation with HIV-1 p24 and envelope glycoprotein. Immunization schedules with both vCP205 and SF-2 rgp120 subunit vaccines induced secretion of Th1 and Th2 cytokines by PBMC to HIV-1 envelope glycoprotein. Hence, vCP205 and SF-2 rgp170 subunit vaccines given together and in a prime-boost sequence appeared to induce a broader cytokine response pattern than vCP205 vaccine given alone. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1806 / 1819
页数:14
相关论文
共 50 条
  • [1] Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
    McFarland, EJ
    Borkowsky, W
    Fenton, T
    Wara, D
    McNamara, J
    Samson, P
    Kang, MH
    Mofenson, L
    Cunningham, C
    Duliege, AM
    Sinangil, F
    Spector, SA
    Jimenez, E
    Bryson, Y
    Burchett, S
    Frenkel, LM
    Yogev, R
    Gigliotti, F
    Luzuriaga, K
    Livingston, RA
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1331 - 1335
  • [2] Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
    Belshe, RB
    Gorse, GJ
    Mulligan, MJ
    Evans, TG
    Keefer, MC
    Excler, JL
    Duliege, AM
    Tartaglia, J
    Cox, WI
    McNamara, J
    Hwang, KL
    Bradney, A
    Montefiori, D
    Weinhold, KJ
    AIDS, 1998, 12 (18) : 2407 - 2415
  • [3] Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults
    Clements-Mann, ML
    Weinhold, K
    Matthews, TJ
    Graham, BS
    Gorse, GJ
    Keefer, MC
    McElrath, MJ
    Hsieh, RH
    Mestecky, J
    Zolla-Pazner, S
    Mascola, J
    Schwartz, D
    Siliciano, R
    Corey, L
    Wright, PF
    Belshe, R
    Dolin, R
    Jackson, S
    Xu, S
    Fast, P
    Walker, MC
    Stablein, D
    Excler, JL
    Tartaglia, J
    Duliege, AM
    Sinangil, F
    Paoletti, E
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05): : 1230 - 1246
  • [4] Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type I (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160
    Fleury, B
    Janvier, G
    Pialoux, G
    Buseyne, F
    Robertson, MN
    Tartaglia, J
    Paoletti, E
    Kieny, MP
    Excler, JL
    Riviere, Y
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 734 - 738
  • [5] Apoptosis induction by human immunodeficiency virus type 1 (HIV-1) gp120 peptides
    Pugliese, O
    Boirivant, M
    Viora, M
    VIRAL IMMUNOLOGY, 1997, 10 (02) : 95 - 102
  • [6] Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine
    Sabbaj, S
    Mulligan, MJ
    Hsieh, RH
    Belshe, RB
    McGhee, JR
    AIDS, 2000, 14 (10) : 1365 - 1374
  • [7] Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gp160 vaccine among adults with advanced HIV infection
    DeMaria, A
    Kunches, L
    Mayer, K
    Cohen, C
    Epstein, P
    Werner, B
    Day, J
    DeCristofaro, J
    Landers, S
    Tang, Y
    Coady, W
    JOURNAL OF HUMAN VIROLOGY, 2000, 3 (04) : 182 - 192
  • [8] Enhanced HIV-1 envelope-tumor protection by a recombinant vaccinia virus expressing anchored HIV-1 gp120 lacking gp41
    Lie, H
    Wright, SE
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 3 (04) : 397 - 400
  • [9] Evaluation of a candidate human immunodeficiency virus type 1 (HIV 1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus
    Stott, EJ
    Almond, N
    Kent, K
    Walker, B
    Hull, R
    Rose, J
    Silvera, P
    Sangster, R
    Corcoran, T
    Lines, J
    Silvera, K
    Luciw, P
    Murphy-Corb, M
    Momin, P
    Bruck, C
    JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 423 - 432
  • [10] COMPLEMENT ACTIVATION BY RECOMBINANT HIV-1 GLYCOPROTEIN GP120
    SUSAL, C
    KIRSCHFINK, M
    KROPELIN, M
    DANIEL, V
    OPELZ, G
    JOURNAL OF IMMUNOLOGY, 1994, 152 (12): : 6028 - 6034